Device Trial Radar · NCT04803214
ReActiv8 Stimulation Therapy vs Optimal Medical Management: A Randomized Evaluation
Last checked: Nov 19, 2026Latest source record: Jan 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
203
Actual
Start
Jul 14, 2021
Primary completion
Sep 4, 2024
Study completion Jan 5, 2026
Sponsor
- Lead sponsor
- Mainstay MedicalNot on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 17, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a prospective, randomized study comparing ReActiv8 Therapy to Optimal Medical Management (OMM).
Conditions
- Chronic Low-back Pain
Interventions
ReActiv8Device
Market-approved ReActiv8 device implanted
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Oswestry Disability Index (ODI)Time frame: 1 year
Locations
28 sites in 1 country. Site status is shown where the registry gives one.
Barrow Brain & Spine
Phoenix, Arizona
University of Arkansas for Medical Sciences
Little Rock, Arkansas
SoCal Sport and Spine
Newport Beach, California
25 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.